Related Experiment Video
Updated: Aug 9, 2026
05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Homocysteine theory of atherosclerosis
1IVth Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Sbornik Lekarsky
|January 1, 1995
Summary
Elevated homocysteine levels are a significant risk factor for atherosclerosis, potentially caused by genetic or dietary factors. Future diagnostics may include homocysteine blood tests and endothelial dysfunction markers.
Area of Science:
- Cardiovascular Science
- Metabolic Research
- Vascular Biology
Background:
- Atherosclerosis is a complex disease involving endothelial injury.
- Hyperhomocysteinemia is an emerging risk factor for atherosclerosis.
- Both genetic and nutritional factors contribute to hyperhomocysteinemia.
Purpose of the Study:
- To review the homocysteine theory of atherosclerosis.
- To highlight the role of endothelial injury in this process.
- To discuss emerging diagnostic approaches for hyperhomocysteinemia.
Main Methods:
- Literature review of the homocysteine theory.
- Discussion of etiological factors for hyperhomocysteinemia.
- Exploration of potential diagnostic markers.
Main Results:
- Homocysteine is a key factor in endothelial injury leading to atherosclerosis.
- Hyperhomocysteinemia affects 30-50% of patients with atherosclerosis.
- Endothelial dysfunction markers, like endothelin levels post-methionine load, are potential future diagnostic tools.
Conclusions:
- Hyperhomocysteinemia is a critical, identifiable risk factor for atherosclerosis.
- Detection methods for homocysteine and endothelial dysfunction are crucial for managing atherosclerosis.
- Integrated diagnostic strategies will improve patient outcomes.
More Related Videos
Related Concept Videos
01:38Inflammation
Overview
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...